PROF Profound Medical Market Cap to Net Assets Ratio

Official company branding of profoundmedical.com (PROF)

The Profound Medical Corp. (PROF) price chart helps assess the strategy of Profound Medical Corp., which relies on the high margins of the TULSA-PRO system for prostate cancer treatment. Regular supplies of consumables ensure a steady cash flow, confirming the metric at the level of 4.04. However, challenges with government insurance and pressure from medtech behemoths in this niche market are hindering growth.

PROF profoundmedical.com: Market Value to Book Value in the range 07/04/2022 - 10/26/2026

PROF (Profound Medical Corp.): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price profoundmedical.com|PROF - Forecast Levels Chart
- market capitalization data:
Market Valuation Profound Medical Corporation|PROF - Aggregate Business Value
- book capitalization data:
Book Value per Share Profound Medical|PROF - Accounting Value of Company|Market Capitalization to Book Value Ratio profoundmedical.com|PROF - Company Assets
- debt and liquidity data:
Debt to Equity Profound Medical Corp.|PROF - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital profoundmedical.com|PROF - Company Aggregate Debts|Debt to Book Capitalization Ratio Profound Medical Corporation
Fundamental valuation:PROF Profound Medical Corp
Original product of Profound Medical Corp.

This ratio measures the market premium over net assets, reflecting investors' willingness to pay a premium over the company's book value. Monitoring changes in the market-to-book value ratio for Profound Medical Corp. (PROF) allows for portfolio stress-testing by assessing the fair value of TULSA-PRO innovative systems and ancillary consumables in the context of their demand from major urological centers.

Competitor analysis

Market Capitalization to Book Value Ratio DexCom, Inc. (DXCM)|Market Capitalization to Net Assets penumbrainc.com|Novanta (NOVT) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple Haemonetics Corp|Inspire Sleep (INSP) - Market Capitalization to Book Value Ratio|Market Value to Book Value Procept (PRCT)|CNMD: Market Capitalization to Book Value Ratio|pulsebiosciences.com - Market-to-Book Ratio|Market Value to Book Value Ratio InMode (INMD)|PMI - Market Value to Book Value|SRDX: Market Capitalization to Book Value Ratio|SENS (Senseonics Holdings, Inc.) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio NeuroPace, Inc. NPCE|Market Capitalization to Net Assets Tactile Systems Technology Inc.|SANUWAVE - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Outset Medical Inc OM|Market Cap to Net Assets Ratio ELMD (Electromed)|LNSR - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio AVITA Medical, Inc. RCEL|BDMD - Market Cap to Book Value Multiple|edap-tms.com - Market Capitalization to Book Value Ratio|Apyx Medical Corporation (APYX) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio ICCM|Market Cap to Net Assets Ratio Pulmonx Corp. (LUNG)|TELA Bio, Inc. (TELA) - Market Cap to Net Assets Ratio|Market Value to Book Value CTSO (cytosorbents.com)|Sensus Healthcare - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Zynex Medical ZYXI|ECOR (electroCore Medical) - Market Capitalization to Book Value Ratio|RBOT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio inspira-technologies.com|seastarmedical.com (ICU) - Capitalization to Book Value Ratio|IRIX: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Intelligent Bio|Market Capitalization to Book Value Ratio XAIR (Beyond Air, Inc.)|Market Cap to Net Assets Ratio Profusa, Inc (PFSA)|Market Capitalization to Book Value Ratio SSKN (STRATA Skin Sciences, Inc.)|GlucoTrack Inc. - Market Capitalization to Book Value Ratio|NAOV - Market Value to Book Value Ratio|Venus Concept Inc (VERO) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio CHF Solutions NUWE|Aethlon Medical Corp (AEMD) - Market Value to Book Value|Market Capitalization to Book Value Ratio ASXC (Asensus Surgical Inc)|Market-to-Book Ratio AVGR|BSGM: Market Value to Book Value Ratio|Market Value to Equity Ratio Cutera Inc. CUTR|Market Cap to Net Assets Ratio KNW (Know Labs Corp)|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Market Capitalization to Book Value Ratio NVRO (Nevro Corp.)|RSLS: Market Capitalization to Book Value|Market Value to Book Value Ratio Silk Road Medical (SILK)